| Product Code: ETC11390191 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite a decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024, Israel saw a continued import of antidepressants from top exporting countries such as Switzerland, UK, Belgium, USA, and Germany in 2024. The low concentration level of the Herfindahl-Hirschman Index (HHI) indicates a diverse market landscape. The slight decrease in growth rate from 2023 to 2024 suggests a stable but modest trend in antidepressant imports. Israel`s reliance on multiple sources for these pharmaceutical products demonstrates a resilient and well-distributed supply chain.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antidepressants Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antidepressants Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antidepressants Market - Industry Life Cycle |
3.4 Israel Antidepressants Market - Porter's Five Forces |
3.5 Israel Antidepressants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Antidepressants Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Israel Antidepressants Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Israel Antidepressants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health issues and the importance of seeking treatment |
4.2.2 Rising prevalence of depression and anxiety disorders in Israel |
4.2.3 Growing acceptance of antidepressant medications as a treatment option |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antidepressant drugs in Israel |
4.3.2 Stigma associated with mental health issues leading to underreporting and underdiagnosis |
4.3.3 Competition from alternative therapies and non-pharmacological treatments |
5 Israel Antidepressants Market Trends |
6 Israel Antidepressants Market, By Types |
6.1 Israel Antidepressants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antidepressants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Antidepressants Market Revenues & Volume, By Prescription, 2021 - 2031F |
6.1.4 Israel Antidepressants Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.2 Israel Antidepressants Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Israel Antidepressants Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.2.3 Israel Antidepressants Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.2.4 Israel Antidepressants Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.3 Israel Antidepressants Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Israel Antidepressants Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Israel Antidepressants Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Israel Antidepressants Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Israel Antidepressants Market Import-Export Trade Statistics |
7.1 Israel Antidepressants Market Export to Major Countries |
7.2 Israel Antidepressants Market Imports from Major Countries |
8 Israel Antidepressants Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted in Israel |
8.2 Percentage increase in prescriptions for antidepressants |
8.3 Patient adherence rates to antidepressant medication |
8.4 Number of clinical trials for new antidepressant drugs conducted in Israel |
8.5 Utilization rates of mental health services in Israel |
9 Israel Antidepressants Market - Opportunity Assessment |
9.1 Israel Antidepressants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Antidepressants Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Israel Antidepressants Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Israel Antidepressants Market - Competitive Landscape |
10.1 Israel Antidepressants Market Revenue Share, By Companies, 2024 |
10.2 Israel Antidepressants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here